statistiche ricercatore

RIVA, CRISTINA

Distribuzione geografica

Continente	#
NA - Nord America	7.073
EU - Europa	4.789
AS - Asia	3.021
SA - Sud America	309
AF - Africa	38
Continente sconosciuto - Info sul continente non disponibili	14
OC - Oceania	4
Totale	15.248

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7.007
IT - Italia	2.246
SG - Singapore	998
UA - Ucraina	802
CN - Cina	681
VN - Vietnam	441
TR - Turchia	385
SE - Svezia	345
DE - Germania	310
HK - Hong Kong	306
BR - Brasile	271
FR - Francia	253
FI - Finlandia	249
IE - Irlanda	204
GB - Regno Unito	156
RU - Federazione Russa	112
IN - India	63
BD - Bangladesh	36
CA - Canada	35
JP - Giappone	30
NL - Olanda	25
MX - Messico	22
BE - Belgio	20
PL - Polonia	18
EU - Europa	13
ZA - Sudafrica	13
AR - Argentina	12
IQ - Iraq	12
SA - Arabia Saudita	9
PK - Pakistan	8
PH - Filippine	7
AT - Austria	6
CH - Svizzera	6
ES - Italia	6
LT - Lituania	6
UZ - Uzbekistan	6
CO - Colombia	5
ID - Indonesia	5
JO - Giordania	5
KE - Kenya	5
AE - Emirati Arabi Uniti	4
DK - Danimarca	4
EC - Ecuador	4
EG - Egitto	4
PE - Perù	4
TN - Tunisia	4
AU - Australia	3
BO - Bolivia	3
CZ - Repubblica Ceca	3
ET - Etiopia	3
HR - Croazia	3
HU - Ungheria	3
LB - Libano	3
MA - Marocco	3
NP - Nepal	3
OM - Oman	3
PY - Paraguay	3
AM - Armenia	2
GE - Georgia	2
LU - Lussemburgo	2
MD - Moldavia	2
MY - Malesia	2
NG - Nigeria	2
PA - Panama	2
SN - Senegal	2
UY - Uruguay	2
VE - Venezuela	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AZ - Azerbaigian	1
CL - Cile	1
CR - Costa Rica	1
DM - Dominica	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
GR - Grecia	1
GY - Guiana	1
HN - Honduras	1
IS - Islanda	1
JM - Giamaica	1
KR - Corea	1
LV - Lettonia	1
MO - Macao, regione amministrativa speciale della Cina	1
MT - Malta	1
MV - Maldive	1
NI - Nicaragua	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PR - Porto Rico	1
PS - Palestinian Territory	1
QA - Qatar	1
RO - Romania	1
RW - Ruanda	1
SK - Slovacchia (Repubblica Slovacca)	1
SR - Suriname	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
TW - Taiwan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	15.248

Salva come PNG Salva come JPEG

Città	#
Milan	1.565
San Jose	618
Jacksonville	608
Chandler	586
Fairfield	578
Singapore	517
Ashburn	473
Woodbridge	388
Dearborn	317
Hong Kong	302
Ann Arbor	280
Houston	254
Wilmington	251
Princeton	214
Seattle	203
Dublin	202
Beijing	201
Izmir	190
Nyköping	183
Cambridge	171
Dallas	144
Boardman	127
Rome	117
The Dalles	116
Dong Ket	110
New York	97
Lauterbourg	93
San Mateo	88
Chicago	87
Los Angeles	83
Ho Chi Minh City	75
Como	71
Council Bluffs	64
Munich	53
San Diego	50
Hanoi	47
Orem	42
Ogden	41
Helsinki	40
Buffalo	29
Guangzhou	29
Hefei	29
Tokyo	29
Santa Clara	27
Chennai	24
São Paulo	24
London	23
Kunming	20
Nanjing	18
Turku	18
Brussels	17
Manchester	16
Warsaw	16
Denver	15
Jinan	15
Verona	15
Atlanta	14
Poplar	14
Norwalk	13
Amsterdam	12
Brooklyn	12
Da Nang	12
Düsseldorf	12
Nanchang	12
Phoenix	12
San Francisco	12
Washington	11
Boston	10
Frankfurt am Main	10
Hangzhou	10
Montreal	10
Toronto	10
Mexico City	9
New Delhi	9
Ankara	8
Catania	8
Haiphong	8
Johannesburg	8
Pune	8
Rio de Janeiro	8
Casorezzo	7
Changsha	7
Fuzhou	7
Shenyang	7
Stockholm	7
Tianjin	7
Auburn Hills	6
Baghdad	6
Biên Hòa	6
Campinas	6
Nuremberg	6
Redwood City	6
Shanghai	6
Vienna	6
Amman	5
Belo Horizonte	5
Chengdu	5
Hải Dương	5
Kocaeli	5
Mumbai	5
Totale	10.382

Salva come PNG Salva come JPEG

Nome	#
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis	301
LUTEOMA GRAVIDICO CON ASCITE MASSIVA: DESCRIZIONE DI UN CASO	280
Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics	258
Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: Case report with genetic and epigenetic analyses	249
Inherited cancer syndromes in 220 Italian ovarian cancer patients	238
Carcinosarcoma of the uterine cervix: Case report and discussion.	237
A cell-autonomous oncosuppressive role of human RNASET2 affecting ECM-mediated oncogenic signaling	231
Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome	229
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.	226
Biochemical and immunohistochemical characterization of human RNASET2 expression	217
Natural history of cervical intraepithelial neoplasia during pregnancy.	216
Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes	213
Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers	211
Primary Extranodal Marginal Cell Lymphoma, MALT Type, of the Endometrium Arising in a Patient With Rheumatoid Arthritis: Report of a Case	208
Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis	207
Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis	203
Renal cell carcinoma metastatic to a pituitary FSH/LH adenoma: Case report and review of the literature	194
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis	193
Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature.	184
Identifying factors contributing to reduced breast tumor size: A longitudinal study	181
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences	175
Early Involvement of 6q in Surface Epithelial Ovarian Tumors	171
"Proximal type" epithelioid sarcoma of the vulva: differential diagnosis with other extrarenal rhabdoid tumors	167
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene	167
Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study	164
Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas	159
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours	157
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells	157
CD44 expression in ER and PR negative ductal breast carcinomas	157
Breast carcinomas with neuroendocrine features are neoplasms of low grade malignancy	157
Disorders of the Endocrine System	154
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms	152
6q27 contains candidate genes involved in surface epithelial ovarian tumors. 4th congress of the European Society for Gynecologic and Obstetric Investigation, Madonna di Campiglio, 14-20 marzo, 1999	152
Fetoplacental cytomegalovirus infection. A case report	152
Chromosome 6 abnormalities in borderline ovarian tumours suggest a genetic continuum in the progression model of ovarian neoplasms.	152
Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer.	151
Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis	150
Adenohypophyseal differentiation in ovarian mature cystic teratomas and in ovarian carcinoids	149
Calretinin expression in different molecular subtypes of ER and PR negative breast carcinomas	147
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations.	145
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001	144
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.	144
Diabetic fibrous mastopathy: sonographic-pathologic correlation	141
IDENTIFICAZIONE E TIPIZZAZIONE DEI GENOTIPI HPV AD ALTO RISCHIO NELLE LESIONI PRENEOPLASTICHE DELLA CERVICE UTERINA: CORRELAZIONI CLINICOPATOLOGICHE	140
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene.	140
Intraoperative radioimmunoguided of colo-rectal cancer using monoclonal antibody B72.3 labelled with 125I	140
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.	139
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts	139
IMMUNOPHENOTYPIC EVALUATION OF ESTROGEN AND PROGESTERONE RECEPTORS NEGATIVE BREAST CARCINOMAS	137
Microsatellite instability in endometrial cancer. Relation to histological subtypes	136
Prognostic significance of karyotype analysis in ovarian carcinomas	135
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas	134
Androgen receptors in breast	134
Clinico-pathological correlations of karyotype analysis in ovarian carcinomas	132
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Neoplasia	132
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro	132
Carcinoma lobulare in situ e invasivo: studio di clonalità con mtDNA	131
Clinicopathological features of oral carcinoma: analysis of 240 cases	128
Espressione del recettore degli androgeni nel carcinoma mammario	127
Ovarian retiform Sertoli-Leydig cell tumor : clinicopathological study of a case, 22th Int Meeting of the Adriatic Society of Pathology	127
METILAZIONE DE NOVO DI p16, hMLH1 E MGMT NEI CARCINOMI SINCRONI ENDOMETRIALI E OVARICI	126
RNASET2 is a non-cell autonomous human tumor suppressor	124
Immunohistochemical expression and methilation status of MGMT in diffuse large B-cells lymphomas	124
Instabilità dei microsatelliti e perdita dell’espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici	122
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment	122
Histopathology, hormone products, and clinico-pathologic profile of endocrine tumors of the small intestine. A study of 44 cases.	121
Chromosome 6 abnormalities in borderline tumors suggest a genetic continuum in the progression model of ovarian neoplasms	119
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression	119
LONG-TERM FOLLOW-UP OF IN SITU CARCINOMA OF THE BREAST	118
Prognostic significance of p53 CA 19-9 and M3SI expression in ovarian carcinomas.	116
Pituitary adenomas, a thirty-four-years experience in a –single institution.	115
“Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas”	114
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas	113
Instabilità dei microsatelliti e perdita dell'espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici	111
Chromosome 6 abnormalities are frequently expressed in Borderline Ovarian Epithelial Tumors suggesting a progression model of ovarian carcinogenesis	111
Capitolo 9.7: Intestino tenue	111
Correlation between microsatellite instability, clinico-pathological and immunohistochemical features in endometrial carcinomas	110
Microsatellite instability and lack of hMLH1 expression in syncronous endometrial and ovarian carcinomas	110
PLACENTAL MALARIA AS A CAUSE OF INTRPAUTERINE FETAL DEATH IN ASYMPTOMATIC PATIENT. A CASE REPORT	108
ESTROGEN RECEPTOR NEGATIVE INVASIVE BREAST CARCINOMAS FREQUENTLY EXPRESS MYOEPITHELIAL MARKERS	108
Non-chromaffin paraganglioma of the cervix uteri. Immunohistochemical and ultrastructural study	108
Ki67, p53 and pttg-1 expression in invasive pituitary adenomas.	105
Er negative, p53 positive, breast cancers frequently express basal and myoepithelial cell markers	104
Clinico - Pathological profile of Estrogen and Progesteron receptors negatibe breast cancinomas with basal or luminal markers expression	103
The applications of FISH in tumor pathology	103
Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas	103
IL CARCINOMA MICROINVASIVO DELLA CERVICE	102
p53 positive, breast cancers frequently express basal and myoepithelial cell markers	102
Frequency and chacterization of anterior pituitary component in ovarian mature cystic teratomas.	102
Ovarian metastases: clinico-pathological profile, immunophenotype and Karyotype analysis	101
Expression of gastrointestinal markers in pancreatic carcinomas	98
Capitolo 9.6: Stomaco	98
Prognostic significance of karyotype analysis in ovarian carcinomas	95
CLINICO-PATHOLOGICAL PROFILE OF ESTROGEN AND PROGESTERONE NEGATIVE BREAST CARCINOMAS WITH BASAL OR LUMINAL MARKERS EXPRESSION	95
Molecular genetics of syncronous endometrial and ovarian carcinomas	95
Correlazioni cisto-isto-colposcopiche in 150 casi consecutivi di patologia cervicale.	95
Gestione per processi in anatomia patologica. Strumenti di analisi del rischio di errore. Azioni correttive e di miglioramento	94
Clinicopathological features of neuroendocrine carcinomas (NECs) of the breast	93
Ano	93
Aspetti clinico-patologici dei teratomi maturi cistici dell’ovaio e caratterizzazione delle componenti endocrine	92
Totale	14.626

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	58.166
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	58.166

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	215	0	0	0	0	0	0	0	0	0	0	0	215
2021/2022	1.054	106	126	96	76	46	37	37	69	53	161	83	164
2022/2023	1.460	127	99	105	195	91	299	3	201	219	35	59	27
2023/2024	2.348	394	388	400	413	470	149	9	17	57	16	17	18
2024/2025	1.448	9	21	264	41	49	59	50	81	214	113	137	410
2025/2026	3.554	263	221	121	569	361	222	717	201	392	249	141	97
Totale													15.314